510(k) · Cleared
ClearedAbc in-Line Blood Sampling Kit
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Utah Medical Products, Inc. · CBT Arterial Blood Sampling Kit
Cleared on Mar 17, 1997 as substantially equivalent to K885281 (Baxter Healthcare Corp, 1989) after a 460-day review. Its family tree reaches back 1 generation to 1989.
- Decided
- Mar 17, 1997
- Review
- 460 days
- Class
- Class I
- Product code
- CBT
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K885281 (1989). No later device cites it as a predicate yet.
- Root · 1 generation backK885281 Vamp Venous/Arterial Blood Management ProtectionBaxter Healthcare Corp · 1989 · Recalled
- This deviceK955663 Abc in-Line Blood Sampling KitUtah Medical Products, Inc. · 1997
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K885281 | Vamp Venous/Arterial Blood Management Protection | Baxter Healthcare Corp | 1989 | 1 |
| 0 (this device) | K955663 | Abc in-Line Blood Sampling Kit | Utah Medical Products, Inc. | 1997 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CBT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K885281 | Vamp Venous/Arterial Blood Management ProtectionSummary page 1…into the patient to reduce fluid loss. Ao =7 e The device is substantially equivalent to the Baxter—V/AthTM blood sampling system cleared for marketing under 510(k) K/885281. “Although the ABC blood collection reservoir is of a different shape and larger capacity compared to the VAMP reservoir, the fre… | 1989 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has a recall.
- 3 other devices also cite its predicate K885281.
How does its category compare?
All CBT devicesCBT Arterial Blood Sampling Kit: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · CBT
2in 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · CBT
Too few CBT 510(k)s in any year since 2007 to give a median.
Recalls per year · CBT
14in 2011
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · CBT
20in 2025
MAUDE reports naming product code CBT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 2 | 5 |
| 2008 | 0 | — | 0 | 10 |
| 2009 | 0 | — | 0 | 7 |
| 2010 | 0 | — | 0 | 20 |
| 2011 | 0 | — | 14 | 6 |
| 2012 | 0 | — | 0 | 14 |
| 2013 | 0 | — | 0 | 13 |
| 2014 | 0 | — | 0 | 6 |
| 2015 | 0 | — | 0 | 10 |
| 2016 | 0 | — | 0 | 30 |
| 2017 | 0 | — | 0 | 22 |
| 2018 | 0 | — | 0 | 15 |
| 2019 | 0 | — | 0 | 19 |
| 2020 | 0 | — | 0 | 10 |
| 2021 | 0 | — | 0 | 24 |
| 2022 | 0 | — | 0 | 13 |
| 2023 | 0 | — | 0 | 13 |
| 2024 | 0 | — | 0 | 25 |
| 2025 | 0 | — | 0 | 20 |
| 2026 | 0 | — | 2 | — |
What is it indicated for?
The ABC (“Arterial Blood Collection) In-Line Blood Sampling Kit is a closed blood sampling system used in conjunction with continuous blood pressure monitoring in a critical care setting. The ABC Kit is designed for use with all disposable and reusable pressure transducers and for connection to central line catheters and arterial catheters. The ABC Kit is used for the drawing and retention within the line of heparinized blood from the catheter/cannula, allowing undiluted blood samples to be drawn from an in-line sampling site. At the completion of sample drawing, the mixed heparin/blood solution is reinfused into the patient to reduce fluid loss.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K955663 · printed Nov 4, 2026
Cite this page
510(k) Report. “K955663: Abc in-Line Blood Sampling Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K955663
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026